Luo RZ - Search Results

1

Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.

Cao X, Chen YZ, Luo RZ, Zhang L, Zhang SL, Zeng J, Jiang YC, Han YJ, Wen ZS. Cao X, et al. Among authors: luo rz. Oncotarget. 2015 May 10;6(13):11704-13. doi: 10.18632/oncotarget.3588. Oncotarget. 2015. PMID: 25868976 Free PMC article.

2

Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study.

Huang ZL, Cao X, Luo RZ, Chen YF, Zhu LC, Wen Z. Huang ZL, et al. Among authors: luo rz. Oncol Lett. 2016 Jan;11(1):299-305. doi: 10.3892/ol.2015.3894. Epub 2015 Nov 9. Oncol Lett. 2016. PMID: 26870207 Free PMC article.

3

Prognostic implications of immune classification based on PD-L1 expression and tumor-infiltrating lymphocytes in endocervical adenocarcinoma.

Wei LJ, Wu ZY, Wu LY, Wu YW, Liang HY, Luo RZ, Liu LL. Wei LJ, et al. Among authors: luo rz. Transl Oncol. 2024 Dec 29;52:102265. doi: 10.1016/j.tranon.2024.102265. Online ahead of print. Transl Oncol. 2024. PMID: 39736213 Free article.

4

Clinicopathological and immune characterization of mismatch repair deficient endocervical adenocarcinoma.

Wu YW, Wei LJ, Yang X, Liang HY, Cai MY, Luo RZ, Liu LL. Wu YW, et al. Among authors: luo rz. Oncologist. 2024 Oct 3;29(10):e1302-e1314. doi: 10.1093/oncolo/oyae192. Oncologist. 2024. PMID: 39110901 Free PMC article.

5

Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer.

Wei LJ, Fu J, Yang HX, Yang X, Liang HY, Luo RZ, Liu LL. Wei LJ, et al. Among authors: luo rz. J Transl Med. 2024 Jul 14;22(1):655. doi: 10.1186/s12967-024-05482-3. J Transl Med. 2024. PMID: 39004706 Free PMC article.

6

PD-L1 expression, morphology, and molecular characteristic of a subset of aggressive uterine tumor resembling ovarian sex cord tumor and a literature review.

Xiong SP, Luo RZ, Wang F, Yang X, Lai JP, Zhang C, Liu LL. Xiong SP, et al. Among authors: luo rz. J Ovarian Res. 2023 May 23;16(1):102. doi: 10.1186/s13048-023-01183-5. J Ovarian Res. 2023. PMID: 37221583 Free PMC article.

7

Non-Hermitian guided modes and exceptional points using loss-free negative-index materials.

Wu LT, Zhang XZ, Luo RZ, Chen J. Wu LT, et al. Among authors: luo rz. Opt Express. 2023 Apr 24;31(9):14109-14118. doi: 10.1364/OE.487278. Opt Express. 2023. PMID: 37157281 Free article.

8

Investigation on risk factors of chronic diseases among community residents: A study based on health management systems supported by Mobile phones.

Luo RZ, Lu Q, Sun Y, Sun H, Liu YH, Zhao Y. Luo RZ, et al. Nurs Open. 2023 Aug;10(8):5117-5128. doi: 10.1002/nop2.1747. Epub 2023 Apr 18. Nurs Open. 2023. PMID: 37071702 Free PMC article.

9

Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction.

Zhao JY, Yuan XK, Luo RZ, Wang LX, Gu W, Yamane D, Feng H. Zhao JY, et al. Among authors: luo rz. Front Immunol. 2023 Mar 31;14:1107239. doi: 10.3389/fimmu.2023.1107239. eCollection 2023. Front Immunol. 2023. PMID: 37063830 Free PMC article. Review.

10

CMTM6 recruits T cells within the endocervical adenocarcinoma microenvironment and suppresses cell proliferation via the p53 pathway.

Liang HY, Chen SL, Cai SH, Zhang SW, Yang X, Wei LJ, Luo RZ, Liu LL. Liang HY, et al. Among authors: luo rz. J Med Virol. 2023 Mar;95(3):e28605. doi: 10.1002/jmv.28605. J Med Virol. 2023. PMID: 36815510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters